Resurgence of bovine thyroid consumption: a rare case of factitious thyrotoxicosis Authors: Zeynep Yagmur Yilmaz, Raihan El-Naas Published: 2026 ABSTRACT AbstractFactitious thyrotoxicosis (FTT) from exogenous thyroid hormone ingestion is an uncommon cause of thyrotoxicosis requiring distinct management from endogenous causes. We report a 19-year-old male patient who developed thyrotoxicosis after consuming raw bovine thyroid purchased online. Laboratory evaluation revealed suppressed thyroid-stimulating hormone, elevated free thyroxine hormone levels, and normal thyroglobulin levels with negative anti-thyroid antibodies and normal thyroid ultrasonography, strongly supporting the diagnosis. The patient was successfully managed with supportive care, and thyroid hormone levels trended downward during hospitalization. Clinicians should obtain detailed dietary and supplement histories when evaluating thyrotoxicosis, as emerging online health trends may promote the consumption of various unusual items such as raw animal organs. Suppressed thyroglobulin is a key diagnostic marker distinguishing FTT from endogenous causes. Introduction Thyrotoxicosis, a clinical syndrome resulting from excessive thyroid hormone, can arise from either endogenous overproduction (hyperthyroidism) or exogenous sources. It can lead to severe cardiac and neurological complications, ranging from palpitations to agitation, and life-threatening thyroid storm [1]. Determining the correct management strategy relies on identifying the underlying etiology. The most common cause of thyrotoxicosis is Graves disease, followed by toxic adenoma and toxic multinodular goiter. In contrast, factitious thyrotoxicosis (FTT) represents a distinct entity caused by iatrogenic, accidental, or malicious ingestion of exogenous thyroid hormone [2]. Although many FTT cases are attributable to the overdosage of synthetic levothyroxine (L-T4), less commonly reported etiologies can significantly complicate the diagnostic process [3]. Rare cases of FTT due to consumption of thyroid tissue-contaminated ground beef have been previously documented in the literature [4, 5]. Even more uncommon is thyrotoxicosis resulting from the consumption of unregulated natural supplements or specialty food products that contain biologically active thyroid tissue [6]. This atypical exposure can obscure the etiology, particularly when patients unknowingly consume the product or withhold information regarding its use, making the determination of the cause more challenging. We report a patient with FTT caused by bovine thyroid tissue consumption, presenting with a profoundly suppressed thyroid-stimulating hormone (TSH) alongside elevated free thyroxine (T4) and total triiodothyronine (T3). This case emphasizes the need to consider uncommon etiologies, including bovine thyroid contamination, when evaluating thyrotoxicosis, particularly in patients with relevant dietary exposures. The diagnosis was confirmed through a systematic diagnostic approach using thyroglobulin measurement and thyroid ultrasonography, highlighting the value of these tools in distinguishing FTT from other causes [3, 7]. Case presentation A 19-year-old man with a history of generalized anxiety disorder presented to the emergency department with palpitations, anxiety, and a few pounds of unintentional weight loss over the preceding few weeks. He reported feeling as though he was going to collapse and feared he was experiencing a heart attack, prompting him to seek emergency care. The patient described the onset of symptoms beginning a few weeks prior, characterized by progressive anxiety, palpitations, nausea, vomiting, and notable weight loss. Despite working out frequently at the gym to gain muscle mass, he experienced progressive weight loss rather than the intended weight gain. He also reported sleep disturbances, alternating between sleeping excessively and experiencing insomnia. He denied neck pain or dysphagia but noted that his throat felt “stuffy.” He denied recent upper respiratory infection symptoms, including rhinorrhea and sore throat. Later, the patient reported that he had become interested in consuming raw organ meats, including veal brain, animal hearts, livers, and thyroid, after learning on an online website that these products could improve his health; hence, he recently obtained a bovine thyroid gland from an online source. He consumed at least half of the bovine thyroid gland approximately 1.5 to 3 weeks (10-20 days) before presenting to the hospital. He described the consumed portion as roughly the size of half of his palm, estimated to be 30 to 50 grams. While he reported consuming the thyroid gland at least once, he could not recall the exact number of times, as he was also consuming other raw organ meats during this period. His motivation was to enhance his liver and other organ function as well as his overall well-being through dietary experimentation. He denied any history of hypothyroidism and was not taking any thyroid medications or supplements, including those containing biotin. On physical examination, vital signs revealed a heart rate ranging from 110 to 140 beats per minute and blood pressure of 120 to 140/80 mmHg. Diagnostic assessment Initial laboratory evaluation demonstrated a markedly suppressed TSH at <0.01 mIU/L (reference range, 0.27-4.20 mIU/L), elevated free T4 at >7.77 ng/dL (SI: >100.02 pmol/L) (reference range, 0.92-1.68 ng/dL [SI: 11.84-21.62 pmol/L]), and elevated total T3 at 552 ng/dL (SI: 8.48 nmol/L) (reference range, 80.0-200.0 ng/dL [SI: 1.23-3.07 nmol/L]). Complete blood count, basic metabolic panel, and liver function tests were unremarkable. Given these findings, an endocrinology consultation was obtained for further evaluation and management. The patient's history of recent bovine thyroid consumption and absence of goiter on physical examination raised suspicion for FTT secondary to exogenous thyroid hormone ingestion. To confirm this diagnosis, thyroid ultrasound and additional thyroid function tests with autoimmune markers were ordered. A thyroid ultrasound demonstrated a normal-sized thyroid gland with normal echogenicity and vascularity without discrete thyroid nodules. Laboratory results obtained on hospital day 2 showed a normal thyroglobulin level at 19.0 ng/mL (19.0 ng/mL) (reference 1.3-31.8 ng/mL [1.3-31.8 ng/mL]) with negative anti-thyroid antibodies, including thyroglobulin antibody, TSH receptor antibody, thyroid-stimulating immunoglobulin (TSI), and thyroid peroxidase antibody (TPO Ab). Complete blood count, comprehensive metabolic panel, and liver function tests remained within normal limits. These findings strongly supported the diagnosis of FTT secondary to exogenous thyroid hormone ingestion from bovine thyroid consumption. Treatment The patient's presentation with severely elevated free T4 levels (>7.77 ng/dL [>100.02 pmol/L]) and tachycardia up to 140 beats per minute raised concern for imminent thyroid storm, warranting aggressive management. The patient remained hemodynamically stable with normal blood pressure. Upon hospitalization, the patient was initiated on methimazole 20 mg 3 times daily and propranolol 20 mg 3 times a day, while the above laboratory and imaging workup was taking place. Intravenous hydrocortisone 100 mg every 8 hours and cholestyramine 4 g 4 times daily were subsequently added to accelerate the clearance of circulating free T4. Given the concern for thyroid storm and severely elevated free T4 levels, plasmapheresis was considered a potential treatment option to rapidly reduce circulating thyroid hormone concentrations if medical management failed. As the laboratory and ultrasound results came in, the diagnosis of FTT from exogenous thyroid hormone ingestion rather than endogenous overproduction was becoming more evident; hence, methimazole was discontinued as ongoing inhibition of endogenous thyroid hormone synthesis was not indicated. The patient's clinical condition continued to improve as his free T4 levels trended downward. Hydrocortisone was gradually tapered from 100 to 50 mg and then to 25 mg every 8 hours before being discontinued entirely. Similarly, cholestyramine was reduced from 4 times daily to twice daily as his free T4 continued to decrease. The patient remained on propranolol 20 mg 3 times daily throughout his hospitalization for symptomatic management. Plasmapheresis was not pursued, given his excellent response to medical treatment. Outcome and follow-up Following appropriate management, the patient demonstrated significant clinical improvement with resolution of tachycardia and symptoms of anxiety. He was discharged on hospital day 7 in stable condition on propranolol 20 mg three times daily and cholestyramine 4 g twice daily. Discharge laboratory values showed TSH <0.01 mIU/L (<0.01 mIU/L), free T4 3.77 ng/dL (SI: 48.52 pmol/L), and a normal total T3 110 ng/dL (SI: 1.69 nmol/L), reflecting overall a downward trend from the initial values on admission (Table 1). An endocrinology follow-up appointment was scheduled 2 weeks after discharge; however, the patient did not attend his scheduled follow-up visit. Table 1Laboratory results during hospitalizationLaboratory TestDay 1Day 2Day 3Day 4Day 5Day 6Day 7Reference RangeTSH (mIU/L)<0.01<0.01<0.01<0.01<0.01<0.01<0.010.27-4.20 mIU/LFree T4 (ng/dL) (pmol/L)>7.77(>100.02 pmol/L)>7.77(>100.02 pmol/L)>7.77(>100.02 pmol/L)7.14 (91.90 pmol/L)6.30 (81.09 pmol/L)4.68 (60.24 pmol/L)3.77 (48.52 pmol/L)0.92-1.68 ng/dL(11.84-21.62 pmol/L)Total T3 (ng/dL) (pmol/L)ND552(8.48 nmol/L)406(6.24 nmol/L)261(4.01 nmol/L)178(2.73 nmol/L)135(2.07 nmol/L)110(1.69 nmol/L)80.0-200.0 ng/dL(1.23-3.07 nmol/L)Thyroglobulin (ng/mL)ND19NDNDNDNDND1.3-31.8 ng/mLAbnormal values are shown in bold. Values in parentheses are International System of Units (SI).Abbreviations: ND, no data; T3, triiodothyronine; T4, thyroxine; TSH, thyrotropin (thyroid-stimulating hormone). Laboratory results during hospitalization Abnormal values are shown in bold. Values in parentheses are International System of Units (SI). Abbreviations: ND, no data; T3, triiodothyronine; T4, thyroxine; TSH, thyrotropin (thyroid-stimulating hormone). Discussion FTT is relatively uncommon and occurs when patients consume excessive exogenous thyroid hormones, often without disclosing this information to their healthcare providers [8]. Most cases involve intentional or accidental overdose of thyroid hormone supplements (eg, levothyroxine, desiccated thyroid, and liothyronine), but consumption of animal thyroid tissue is a rare and thus frequently overlooked cause. Historical cases of “hamburger thyrotoxicosis” occurred when bovine thyroid glands were accidentally incorporated into ground meat during processing [4, 5]. In contrast, deliberate consumption of bovine thyroid is very rare and reflects emerging dietary trends in which raw organ meat consumption is sometimes promoted on various online media platforms. Some individuals intentionally consume thyroid hormones to increase their metabolism and promote weight loss while maintaining muscle mass [8]. Moreover, FTT has been seen in patients with psychiatric disorders, particularly eating disorders for weight reduction, and Munchausen syndrome, characterized by fabricating false illnesses to gain medical attention [9, 10]. The diagnostic approach to thyrotoxicosis, whether from endogenous hyperthyroidism or exogenous sources, relies on establishing the correct etiology to guide appropriate management [11, 12]. A thorough dietary and supplement history is crucial, as patients may not disclose consumption of unconventional food products or supplements, and they may be unaware of their potential risks [6]. In FTT, the combination of suppressed TSH, elevated free T4, high total T3, normal thyroglobulin levels, negative anti-thyroid antibody levels, absent thyroid goiter on physical examination, and normal thyroid appearance on ultrasound establishes the diagnosis. Thyroglobulin measurement is essential in differentiating FTT from Graves disease or destructive thyroiditis, as endogenous thyroid hormone overproduction elevates thyroglobulin levels, whereas exogenous intake suppresses them [3, 7]. A thyroid radioiodine uptake test can further differentiate causes of thyrotoxicosis, demonstrating diffusely increased uptake in Graves disease, multifocal increased uptake in toxic multinodular goiter, and a localized uptake in toxic adenoma vs very low uptake in destructive thyroiditis and exogenous thyroid hormone ingestion [13]. This test was not performed in our case as the combination of clinical presentation, laboratory findings, and ultrasound imaging provided sufficient diagnostic clarity. The fecal thyroxine test is another test that can support the diagnosis of exogenous thyroid hormone ingestion when recent consumption is suspected, and its use has been previously reported in a couple of cases [14]. This test was not obtained in our patient due to difficulty collecting a stool sample; however, its diagnostic utility would likely have been limited, given the reported consumption occurred 1.5 to 3 weeks before presentation with uncertain frequency. Management of FTT differs fundamentally from Graves disease. Antithyroid drugs, which inhibit endogenous thyroid hormone synthesis, are ineffective and should be discontinued once the diagnosis is confirmed [11, 12]. Treatment focuses on supportive measures, including beta-blockers for symptomatic relief and bile acid sequestrants such as cholestyramine to interrupt enterohepatic circulation and accelerate thyroid hormone clearance [3]. Corticosteroids may be considered in severe cases to reduce peripheral conversion of T4 to T3 [12]. Our case was limited by the absence of long-term follow-up data, preventing assessment of complete thyroid function recovery and dietary counseling effectiveness. This highlights the importance of patient education and close endocrinologic monitoring following discharge. Learning points Bovine thyroid consumption is a rare cause of FTT that should be considered in patients with unconventional dietary practices, particularly those influenced by online health trends. Bovine thyroid consumption is a rare cause of FTT that should be considered in patients with unconventional dietary practices, particularly those influenced by online health trends. A thorough dietary and supplement history is essential when evaluating thyrotoxicosis, as patients may be unaware that their products contain thyroid tissue. A thorough dietary and supplement history is essential when evaluating thyrotoxicosis, as patients may be unaware that their products contain thyroid tissue. Suppressed or normal thyroglobulin levels with elevated T4 and T3 levels help distinguish FTT from endogenous causes like Graves disease or thyroiditis. Suppressed or normal thyroglobulin levels with elevated T4 and T3 levels help distinguish FTT from endogenous causes like Graves disease or thyroiditis. Contributors All authors contributed individually to the authorship. R.E. was involved in the diagnosis and management of this patient. Z.Y.Y. was involved in clinical data interpretation and literature search. All authors reviewed and approved the final draft.